Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML

Clinical trial NCT07451912 · RECRUITING

Trial details

NCT number: NCT07451912
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)CEBPA Mutation Unfit, New-diagnosis AML

Start date: 2025-09-15
Primary completion: 2027-09-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.